Leucomycin V,9-deoxy-12,13-epoxy-12,13-dihydro-9-oxo-, 3-acetate 4B-(3-methylbutanoate),(12S,13S)-

Suppliers

Names

[ CAS No. ]:
4564-87-8

[ Name ]:
Leucomycin V,9-deoxy-12,13-epoxy-12,13-dihydro-9-oxo-, 3-acetate 4B-(3-methylbutanoate),(12S,13S)-

[Synonym ]:
DeltaMycin A4
M 4209
Magnamycin-A
MagnaMycin
carbomycin
CarboMycin A

Chemical & Physical Properties

[ Density]:
1.24g/cm3

[ Boiling Point ]:
892.2ºC at 760mmHg

[ Melting Point ]:
214ºC

[ Molecular Formula ]:
C42H67NO16

[ Molecular Weight ]:
841.97800

[ Flash Point ]:
493.4ºC

[ Exact Mass ]:
841.44600

[ PSA ]:
215.42000

[ LogP ]:
2.43280

[ Index of Refraction ]:
1.535

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OH4727000
CHEMICAL NAME :
Leucomycin V, 9-deoxy-12,13-epoxy-12,13-dihydro-9-oxo-, 3-acetate 4B-(3-methylbutanoate), (12S,13S)-
CAS REGISTRY NUMBER :
4564-87-8
LAST UPDATED :
199706
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C42-H67-N-O16
MOLECULAR WEIGHT :
842.10

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ABANAE Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ. Volume(issue)/page/year: 2,336,1954/1955
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2950 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. Volume(issue)/page/year: 3,117,1953
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. Volume(issue)/page/year: 3,117,1953
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ANTCAO Antibiotics and Chemotherapy (Washington, DC). (Washington, DC) V.1-12, 1951-62. For publisher information, see CLMEA3. Volume(issue)/page/year: 3,117,1953

Related Compounds

  • 4-[5-Amino-1-(4-methoxy-phenyl)-1h-[1,2,4]triazol-3-ylamino]-benzoic acid
  • Poly(oxy-1,2-ethanediyl), I+/-,I+/-a(2)-[1,2-diazenediylbis(4-cyano-4-methyl-1-oxo-4,1-butanediyl)]bis[I-methoxy-
  • 2-(aminomethyl)-N-(2-methoxyethyl)-N-methylaniline
  • Volixibat potassium monoethanolate monohydrate
  • 1-(4-Methoxybenzyl)-1-methylguanidine hydrochloride
  • 4-Fluoro-2-(prop-2-yn-1-yloxy)aniline
  • 1-[3-[2-(1-Oxidobenzo[b]thien-5-yl)ethoxy]propyl]-3-azetidinol
  • 2-[N-methyl2-(4-methylphenyl)ethenesulfonamido]acetamide
  • N~5~-(Diaminomethylidene)-L-ornithyl-L-methionyl-L-seryl-L-asparaginyl-L-leucyl-L-alanyl-L-serine
  • 2-methyl-2-(5-nitro-1H-indol-2-yl)propan-1-ol
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.